Stay updated on SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial page.

Latest updates to the SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now indicates recruitment is closed with the line 'No longer looking for participants'. The revision metadata has been updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check18 days agoChange DetectedRevision: v3.5.5 is now displayed, replacing the previous Revision: v3.5.4. This appears to be a version update of the site rather than a change to the page content.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a new page release. This change does not modify any page content or behavior.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page revision label has been updated from **v3.5.0** to **v3.5.3**, reflecting a backend/software version change without altering the displayed study record content.SummaryDifference0.0%

- Check96 days agoChange DetectedAdded site revision note: v3.5.0 and removed the Glossary. The previous revision entry v3.4.3 was also deleted.SummaryDifference0.2%

- Check110 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3. No visible changes to study data or page structure were observed.SummaryDifference0.0%

Stay in the know with updates to SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SubQ Pertuzumab/Trastuzumab Preference in Early Breast Cancer Clinical Trial page.